Ecstasy Healthcare Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 28-05-2024
- Paid Up Capital ₹ 0.10 M
as on 28-05-2024
- Company Age 9 Year, 3 Months
- Last Filing with ROC 31 Mar 2021
- Revenue 941.93%
(FY 2019)
- Profit 674.36%
(FY 2019)
- Ebitda 560.64%
(FY 2019)
- Net Worth 658.58%
(FY 2019)
- Total Assets 0.90%
(FY 2019)
About Ecstasy Healthcare
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Kaushal Tingre, Abhilash More, Amol Pardeshi, and One other member serve as directors at the Company.
- CIN/LLPIN
U85300PN2015PTC156560
- Company No.
156560
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Sep 2015
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Ecstasy Healthcare Private Limited offer?
Ecstasy Healthcare Private Limited offers a wide range of products and services, including Physiotherapy & Rehab Aids, Fracture Aid, Common Disease Medicines, Injectable Products, Anti Infective Drugs & Medicines, Antibacterial Drugs, HIV Drugs, Forceps & Graspers, Surgical Staplers, Nutraceuticals & Dietary Supplements.
Who are the key members and board of directors at Ecstasy Healthcare?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rohit Mane  | Director | 24-Sep-2015 | Current |
| Kaushal Tingre | Additional Director | 17-Mar-2022 | Current |
| Abhilash More | Director | 10-Feb-2018 | Current |
| Amol Pardeshi | Director | 10-Feb-2018 | Current |
Financial Performance of Ecstasy Healthcare.
Ecstasy Healthcare Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 941.93% increase. The company also saw a substantial improvement in profitability, with a 674.36% increase in profit. The company's net worth Soared by an impressive increase of 658.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ecstasy Healthcare?
In 2017, Ecstasy Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ecstasy Healthcare?
Unlock and access historical data on people associated with Ecstasy Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ecstasy Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ecstasy Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
